Strategic Restructuring Initiatives
The company has restructured by divesting the non-core AT&M business and folded the medical CMO business into the EMS portfolio. This strategic shift is aimed at focusing on key growing areas such as Automotive, Industrial, and Medical.
Balance Sheet Improvement
Significant positive cash flow generated by reducing inventory levels by over $150 million and paying down nearly $50 million in debt, reaching a 2-year low debt level.
Streamlining and Efficiency Gains
Announced closure of Tampa manufacturing facility to drive efficiency and invest in core business growth. The move aims to leverage global footprint capacity and improve competitiveness.
Inventory Reduction Success
Inventory levels reduced by $147 million, representing a 30% reduction compared to the previous year.
Confirmed Guidance for Fiscal Year 2025
Guidance includes net sales between $1.44 billion to $1.54 billion and adjusted operating income of 4% to 4.5% of net sales.